Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 319 entries
Sorted by: Best Match Show Resources per page
Progranulin Mutations Affects Brain Oscillatory Activity in Fronto-Temporal Dementia.

Frontiers in aging neuroscience

Moretti DV, Benussi L, Fostinelli S, Ciani M, Binetti G, Ghidoni R.
PMID: 26973510
Front Aging Neurosci. 2016 Feb 29;8:35. doi: 10.3389/fnagi.2016.00035. eCollection 2016.

BACKGROUND: Mild cognitive impairment (MCI) is a clinical stage indicating a prodromal phase of dementia. This practical concept could be used also for fronto-temporal dementia (FTD). Progranulin (PGRN) has been recently recognized as a useful diagnostic biomarker for fronto-temporal...

Cite
Moretti DV, Benussi L, Fostinelli S, et al. Progranulin Mutations Affects Brain Oscillatory Activity in Fronto-Temporal Dementia. Front Aging Neurosci. 2016;8:35doi: 10.3389/fnagi.2016.00035.
Moretti, D. V., Benussi, L., Fostinelli, S., Ciani, M., Binetti, G., & Ghidoni, R. (2016). Progranulin Mutations Affects Brain Oscillatory Activity in Fronto-Temporal Dementia. Frontiers in aging neuroscience, 835. https://doi.org/10.3389/fnagi.2016.00035
Moretti, Davide V, et al. "Progranulin Mutations Affects Brain Oscillatory Activity in Fronto-Temporal Dementia." Frontiers in aging neuroscience vol. 8 (2016): 35. doi: https://doi.org/10.3389/fnagi.2016.00035
Moretti DV, Benussi L, Fostinelli S, Ciani M, Binetti G, Ghidoni R. Progranulin Mutations Affects Brain Oscillatory Activity in Fronto-Temporal Dementia. Front Aging Neurosci. 2016 Feb 29;8:35. doi: 10.3389/fnagi.2016.00035. eCollection 2016. PMID: 26973510; PMCID: PMC4770190.
Copy Download .nbib Format: NLM
Extra-abdominal fibromatosis: Clinical and therapeutic considerations based on an illustrative case.

Oncology letters

Fornaro R, Caratto E, Caratto M, Salerno A, Sarocchi F, Minetti G, Frascio M, Murialdo R, Taviani M.
PMID: 26722296
Oncol Lett. 2015 Nov;10(5):3103-3106. doi: 10.3892/ol.2015.3684. Epub 2015 Sep 08.

Extra-abdominal fibromatosis is a rare, benign disease that is characterized by a local but not metastatic invasivity. In particular, desmoid tumors of the chest wall represent only 10-20% of all deep fibromatoses. The disease occurs more often in females...

Cite
Fornaro R, Caratto E, Caratto M, et al. Extra-abdominal fibromatosis: Clinical and therapeutic considerations based on an illustrative case. Oncol Lett. 2015;10(5):3103-3106doi: 10.3892/ol.2015.3684.
Fornaro, R., Caratto, E., Caratto, M., Salerno, A., Sarocchi, F., Minetti, G., Frascio, M., Murialdo, R., & Taviani, M. (2015). Extra-abdominal fibromatosis: Clinical and therapeutic considerations based on an illustrative case. Oncology letters, 10(5), 3103-3106. https://doi.org/10.3892/ol.2015.3684
Fornaro, Rosario, et al. "Extra-abdominal fibromatosis: Clinical and therapeutic considerations based on an illustrative case." Oncology letters vol. 10,5 (2015): 3103-3106. doi: https://doi.org/10.3892/ol.2015.3684
Fornaro R, Caratto E, Caratto M, Salerno A, Sarocchi F, Minetti G, Frascio M, Murialdo R, Taviani M. Extra-abdominal fibromatosis: Clinical and therapeutic considerations based on an illustrative case. Oncol Lett. 2015 Nov;10(5):3103-3106. doi: 10.3892/ol.2015.3684. Epub 2015 Sep 08. PMID: 26722296; PMCID: PMC4665811.
Copy Download .nbib Format: NLM
Erratum to "Intubation and extubation of the ICU patient" [Anaesth. Crit. Care Pain Med. 36 (5) (2017) 327-341].

Anaesthesia, critical care & pain medicine

Quintard H, l'Her E, Pottecher J, Adnet F, Constantin JM, De Jong A, Diemunsch P, Fesseau R, Freynet A, Girault C, Guitton C, Hamonic Y, Maury E, Mekontso-Dessap A, Michel F, Nolent P, Perbet S, Prat G, Roquilly A, Tazarourte K, Terzi N, Thille AW, Alves M, Gayat E, Donetti L.
PMID: 29578076
Anaesth Crit Care Pain Med. 2018 Jun;37(3):295-296. doi: 10.1016/j.accpm.2018.03.005. Epub 2018 Mar 22.

No abstract available.

Cite
Quintard H, l'Her E, Pottecher J, et al. Erratum to "Intubation and extubation of the ICU patient" [Anaesth. Crit. Care Pain Med. 36 (5) (2017) 327-341]. Anaesth Crit Care Pain Med. 2018;37(3):295-296doi: 10.1016/j.accpm.2018.03.005.
Quintard, H., l'Her, E., Pottecher, J., Adnet, F., Constantin, J. M., De Jong, A., Diemunsch, P., Fesseau, R., Freynet, A., Girault, C., Guitton, C., Hamonic, Y., Maury, E., Mekontso-Dessap, A., Michel, F., Nolent, P., Perbet, S., Prat, G., Roquilly, A., Tazarourte, K., Terzi, N., Thille, A. W., Alves, M., Gayat, E., & Donetti, L. (2018). Erratum to "Intubation and extubation of the ICU patient" [Anaesth. Crit. Care Pain Med. 36 (5) (2017) 327-341]. Anaesthesia, critical care & pain medicine, 37(3), 295-296. https://doi.org/10.1016/j.accpm.2018.03.005
Quintard, H, et al. "Erratum to "Intubation and extubation of the ICU patient" [Anaesth. Crit. Care Pain Med. 36 (5) (2017) 327-341]." Anaesthesia, critical care & pain medicine vol. 37,3 (2018): 295-296. doi: https://doi.org/10.1016/j.accpm.2018.03.005
Quintard H, l'Her E, Pottecher J, Adnet F, Constantin JM, De Jong A, Diemunsch P, Fesseau R, Freynet A, Girault C, Guitton C, Hamonic Y, Maury E, Mekontso-Dessap A, Michel F, Nolent P, Perbet S, Prat G, Roquilly A, Tazarourte K, Terzi N, Thille AW, Alves M, Gayat E, Donetti L. Erratum to "Intubation and extubation of the ICU patient" [Anaesth. Crit. Care Pain Med. 36 (5) (2017) 327-341]. Anaesth Crit Care Pain Med. 2018 Jun;37(3):295-296. doi: 10.1016/j.accpm.2018.03.005. Epub 2018 Mar 22. PMID: 29578076.
Copy Download .nbib Format: NLM
The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers.

Oncoimmunology

Bertucci F, Finetti P, Birnbaum D, Mamessier E.
PMID: 27141340
Oncoimmunology. 2015 Aug 31;5(3):e1085148. doi: 10.1080/2162402X.2015.1085148. eCollection 2016 Mar.

Analysis of

Cite
Bertucci F, Finetti P, Birnbaum D, et al. The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers. Oncoimmunology. 2015;5(3):e1085148doi: 10.1080/2162402X.2015.1085148.
Bertucci, F., Finetti, P., Birnbaum, D., & Mamessier, E. (2016). The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers. Oncoimmunology, 5(3), e1085148. https://doi.org/10.1080/2162402X.2015.1085148
Bertucci, François, et al. "The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers." Oncoimmunology vol. 5,3 (2016): e1085148. doi: https://doi.org/10.1080/2162402X.2015.1085148
Bertucci F, Finetti P, Birnbaum D, Mamessier E. The PD1/PDL1 axis, a promising therapeutic target in aggressive breast cancers. Oncoimmunology. 2015 Aug 31;5(3):e1085148. doi: 10.1080/2162402X.2015.1085148. eCollection 2016 Mar. PMID: 27141340; PMCID: PMC4839307.
Copy Download .nbib Format: NLM
Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy.

Neuropsychiatric disease and treatment

Moretti DV, Binetti G, Zanetti O, Frisoni GB.
PMID: 24940065
Neuropsychiatr Dis Treat. 2014 Jun 05;10:1003-9. doi: 10.2147/NDT.S64015. eCollection 2014.

Transdermal rotigotine (RTG) is a non-ergot dopamine agonist (D3>D2>D1), and is indicated for use in early and advanced Parkinson's disease (PD). RTG patch has many potential advantages due to the immediacy of onset of the therapeutic effect. Of note,...

Cite
Moretti DV, Binetti G, Zanetti O, et al. Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy. Neuropsychiatr Dis Treat. 2014;10:1003-9doi: 10.2147/NDT.S64015.
Moretti, D. V., Binetti, G., Zanetti, O., & Frisoni, G. B. (2014). Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy. Neuropsychiatric disease and treatment, 101003-9. https://doi.org/10.2147/NDT.S64015
Moretti, Davide Vito, et al. "Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy." Neuropsychiatric disease and treatment vol. 10 (2014): 1003-9. doi: https://doi.org/10.2147/NDT.S64015
Moretti DV, Binetti G, Zanetti O, Frisoni GB. Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both α-synucleinopathy and tauopathy. Neuropsychiatr Dis Treat. 2014 Jun 05;10:1003-9. doi: 10.2147/NDT.S64015. eCollection 2014. PMID: 24940065; PMCID: PMC4051815.
Copy Download .nbib Format: NLM
Prediction of early breast cancer metastasis from DNA microarray data using high-dimensional cox regression models.

Cancer informatics

Zemmour C, Bertucci F, Finetti P, Chetrit B, Birnbaum D, Filleron T, Boher JM.
PMID: 25983547
Cancer Inform. 2015 May 05;14:129-38. doi: 10.4137/CIN.S17284. eCollection 2015.

BACKGROUND: DNA microarray studies identified gene expression signatures predictive of metastatic relapse in early breast cancer. Standard feature selection procedures applied to reduce the set of predictive genes did not take into account the correlation between genes. In this...

Cite
Zemmour C, Bertucci F, Finetti P, et al. Prediction of early breast cancer metastasis from DNA microarray data using high-dimensional cox regression models. Cancer Inform. 2015;14:129-38doi: 10.4137/CIN.S17284.
Zemmour, C., Bertucci, F., Finetti, P., Chetrit, B., Birnbaum, D., Filleron, T., & Boher, J. M. (2015). Prediction of early breast cancer metastasis from DNA microarray data using high-dimensional cox regression models. Cancer informatics, 14129-38. https://doi.org/10.4137/CIN.S17284
Zemmour, Christophe, et al. "Prediction of early breast cancer metastasis from DNA microarray data using high-dimensional cox regression models." Cancer informatics vol. 14 (2015): 129-38. doi: https://doi.org/10.4137/CIN.S17284
Zemmour C, Bertucci F, Finetti P, Chetrit B, Birnbaum D, Filleron T, Boher JM. Prediction of early breast cancer metastasis from DNA microarray data using high-dimensional cox regression models. Cancer Inform. 2015 May 05;14:129-38. doi: 10.4137/CIN.S17284. eCollection 2015. PMID: 25983547; PMCID: PMC4426954.
Copy Download .nbib Format: NLM
Novel GABRG2 mutations cause familial febrile seizures.

Neurology. Genetics

Boillot M, Morin-Brureau M, Picard F, Weckhuysen S, Lambrecq V, Minetti C, Striano P, Zara F, Iacomino M, Ishida S, An-Gourfinkel I, Daniau M, Hardies K, Baulac M, Dulac O, Leguern E, Nabbout R, Baulac S.
PMID: 27066572
Neurol Genet. 2015 Nov 04;1(4):e35. doi: 10.1212/NXG.0000000000000035. eCollection 2015 Dec.

OBJECTIVE: To identify the genetic cause in a large family with febrile seizures (FS) and temporal lobe epilepsy (TLE) and subsequently search for additional mutations in a cohort of 107 families with FS, with or without epilepsy.METHODS: The cohort...

Cite
Boillot M, Morin-Brureau M, Picard F, et al. Novel GABRG2 mutations cause familial febrile seizures. Neurol Genet. 2015;1(4):e35doi: 10.1212/NXG.0000000000000035.
Boillot, M., Morin-Brureau, M., Picard, F., Weckhuysen, S., Lambrecq, V., Minetti, C., Striano, P., Zara, F., Iacomino, M., Ishida, S., An-Gourfinkel, I., Daniau, M., Hardies, K., Baulac, M., Dulac, O., Leguern, E., Nabbout, R., & Baulac, S. (2015). Novel GABRG2 mutations cause familial febrile seizures. Neurology. Genetics, 1(4), e35. https://doi.org/10.1212/NXG.0000000000000035
Boillot, Morgane, et al. "Novel GABRG2 mutations cause familial febrile seizures." Neurology. Genetics vol. 1,4 (2015): e35. doi: https://doi.org/10.1212/NXG.0000000000000035
Boillot M, Morin-Brureau M, Picard F, Weckhuysen S, Lambrecq V, Minetti C, Striano P, Zara F, Iacomino M, Ishida S, An-Gourfinkel I, Daniau M, Hardies K, Baulac M, Dulac O, Leguern E, Nabbout R, Baulac S. Novel GABRG2 mutations cause familial febrile seizures. Neurol Genet. 2015 Nov 04;1(4):e35. doi: 10.1212/NXG.0000000000000035. eCollection 2015 Dec. PMID: 27066572; PMCID: PMC4811385.
Copy Download .nbib Format: NLM
Approaching Free Fall on Two Degrees of Freedom: Simultaneous Measurement of Residual Force and Torque on a Double Torsion Pendulum.

Physical review letters

Bassan M, Cavalleri A, De Laurentis M, De Marchi F, De Rosa R, Di Fiore L, Dolesi R, Finetti N, Garufi F, Grado A, Hueller M, Marconi L, Milano L, Pucacco G, Stanga R, Visco M, Vitale S, Weber WJ.
PMID: 26894698
Phys Rev Lett. 2016 Feb 05;116(5):051104. doi: 10.1103/PhysRevLett.116.051104. Epub 2016 Feb 05.

A torsion pendulum with 2 soft degrees of freedom (DOFs), realized by off-axis cascading two torsion fibers, has been built and operated. This instrument helps characterize the geodesic motion of a test mass for LISA Pathfinder or any other...

Cite
Bassan M, Cavalleri A, De Laurentis M, et al. Approaching Free Fall on Two Degrees of Freedom: Simultaneous Measurement of Residual Force and Torque on a Double Torsion Pendulum. Phys Rev Lett. 2016;116(5):051104doi: 10.1103/PhysRevLett.116.051104.
Bassan, M., Cavalleri, A., De Laurentis, M., De Marchi, F., De Rosa, R., Di Fiore, L., Dolesi, R., Finetti, N., Garufi, F., Grado, A., Hueller, M., Marconi, L., Milano, L., Pucacco, G., Stanga, R., Visco, M., Vitale, S., & Weber, W. J. (2016). Approaching Free Fall on Two Degrees of Freedom: Simultaneous Measurement of Residual Force and Torque on a Double Torsion Pendulum. Physical review letters, 116(5), 051104. https://doi.org/10.1103/PhysRevLett.116.051104
Bassan, M, et al. "Approaching Free Fall on Two Degrees of Freedom: Simultaneous Measurement of Residual Force and Torque on a Double Torsion Pendulum." Physical review letters vol. 116,5 (2016): 051104. doi: https://doi.org/10.1103/PhysRevLett.116.051104
Bassan M, Cavalleri A, De Laurentis M, De Marchi F, De Rosa R, Di Fiore L, Dolesi R, Finetti N, Garufi F, Grado A, Hueller M, Marconi L, Milano L, Pucacco G, Stanga R, Visco M, Vitale S, Weber WJ. Approaching Free Fall on Two Degrees of Freedom: Simultaneous Measurement of Residual Force and Torque on a Double Torsion Pendulum. Phys Rev Lett. 2016 Feb 05;116(5):051104. doi: 10.1103/PhysRevLett.116.051104. Epub 2016 Feb 05. PMID: 26894698.
Copy Download .nbib Format: NLM
XPO1, therapeutic … and prognostic target in sarcomas.

Oncoscience

Bertucci F, Finetti P, Birnbaum D.
PMID: 27487856
Oncoscience. 2016 May 19;3(5):143-4. doi: 10.18632/oncoscience.304. eCollection 2016.

No abstract available.

Cite
Bertucci F, Finetti P, Birnbaum D. XPO1, therapeutic … and prognostic target in sarcomas. Oncoscience. 2016;3(5):143-4doi: 10.18632/oncoscience.304.
Bertucci, F., Finetti, P., & Birnbaum, D. (2016). XPO1, therapeutic … and prognostic target in sarcomas. Oncoscience, 3(5), 143-4. https://doi.org/10.18632/oncoscience.304
Bertucci, François, et al. "XPO1, therapeutic … and prognostic target in sarcomas." Oncoscience vol. 3,5 (2016): 143-4. doi: https://doi.org/10.18632/oncoscience.304
Bertucci F, Finetti P, Birnbaum D. XPO1, therapeutic … and prognostic target in sarcomas. Oncoscience. 2016 May 19;3(5):143-4. doi: 10.18632/oncoscience.304. eCollection 2016. PMID: 27487856; PMCID: PMC4965254.
Copy Download .nbib Format: NLM
PDL1 expression is an independent prognostic factor in localized GIST.

Oncoimmunology

Bertucci F, Finetti P, Mamessier E, Pantaleo MA, Astolfi A, Ostrowski J, Birnbaum D.
PMID: 26155391
Oncoimmunology. 2015 Feb 03;4(5):e1002729. doi: 10.1080/2162402X.2014.1002729. eCollection 2015 May.

Gastrointestinal stromal tumors (GIST) are the most frequently occurring digestive sarcomas. The prognosis of localized GIST is heterogeneous, notably for patients with an Armed Forces Institute of Pathology (AFIP) intermediate or high risk of relapse. Despite imatinib effectiveness, it...

Cite
Bertucci F, Finetti P, Mamessier E, et al. PDL1 expression is an independent prognostic factor in localized GIST. Oncoimmunology. 2015;4(5):e1002729doi: 10.1080/2162402X.2014.1002729.
Bertucci, F., Finetti, P., Mamessier, E., Pantaleo, M. A., Astolfi, A., Ostrowski, J., & Birnbaum, D. (2015). PDL1 expression is an independent prognostic factor in localized GIST. Oncoimmunology, 4(5), e1002729. https://doi.org/10.1080/2162402X.2014.1002729
Bertucci, François, et al. "PDL1 expression is an independent prognostic factor in localized GIST." Oncoimmunology vol. 4,5 (2015): e1002729. doi: https://doi.org/10.1080/2162402X.2014.1002729
Bertucci F, Finetti P, Mamessier E, Pantaleo MA, Astolfi A, Ostrowski J, Birnbaum D. PDL1 expression is an independent prognostic factor in localized GIST. Oncoimmunology. 2015 Feb 03;4(5):e1002729. doi: 10.1080/2162402X.2014.1002729. eCollection 2015 May. PMID: 26155391; PMCID: PMC4485716.
Copy Download .nbib Format: NLM
Muscle and the cerebellum.

The neuroradiology journal

Biancheri R, Rossi A, Bruno C, Minetti C.
PMID: 24299703
Neuroradiol J. 2007 Aug 31;20(4):427-33. doi: 10.1177/197140090702000407. Epub 2007 Aug 31.

No abstract available.

Cite
Biancheri R, Rossi A, Bruno C, et al. Muscle and the cerebellum. Neuroradiol J. 2007;20(4):427-33doi: 10.1177/197140090702000407.
Biancheri, R., Rossi, A., Bruno, C., & Minetti, C. (2007). Muscle and the cerebellum. The neuroradiology journal, 20(4), 427-33. https://doi.org/10.1177/197140090702000407
Biancheri, R, et al. "Muscle and the cerebellum." The neuroradiology journal vol. 20,4 (2007): 427-33. doi: https://doi.org/10.1177/197140090702000407
Biancheri R, Rossi A, Bruno C, Minetti C. Muscle and the cerebellum. Neuroradiol J. 2007 Aug 31;20(4):427-33. doi: 10.1177/197140090702000407. Epub 2007 Aug 31. PMID: 24299703.
Copy Download .nbib Format: NLM
[Priority objective of medical education].

La Clinica terapeutica

Binetti P, Albano MG.
PMID: 10958048
Clin Ter. 2000 May-Jun;151(3):155-65.

PURPOSE: To analyze the Best Evidence Medical Education approach (BEME) in relation to the need of improving the quality of education in medical faculties through strictly controlled forms of experiments.MATERIALS AND METHOD: Starting from the analysis of several Medical...

Cite
Binetti P, Albano MG. Obiettivo prioritario dell'educazione medica. [Priority objective of medical education]. Clin Ter. 2000;151(3):155-65
Binetti, P., & Albano, M. G. (2000). Obiettivo prioritario dell'educazione medica. [Priority objective of medical education]. La Clinica terapeutica, 151(3), 155-65.
Binetti, P, and Albano, M G. "Obiettivo prioritario dell'educazione medica." [Priority objective of medical education]. La Clinica terapeutica vol. 151,3 (2000): 155-65.
Binetti P, Albano MG. Obiettivo prioritario dell'educazione medica. [Priority objective of medical education]. Clin Ter. 2000 May-Jun;151(3):155-65. Italian. PMID: 10958048.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 319 entries